TargetMol

Libenzapril

Product Code:
 
TAR-T27827
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T27827-1mg1mg£271.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27827-5mg5mg£571.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27827-10mg10mg£783.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27827-25mg25mg£1,139.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27827-50mg50mg£1,500.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T27827-100mg100mg£2,022.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Libenzapril is an inhibitor of angiotensin-converting enzyme.
CAS:
109214-55-3
Formula:
C18H25N3O5
Molecular Weight:
363.414
Pathway:
Metabolism
Purity:
0.98
SMILES:
NCCCC[C@H](N[C@H]1CCc2ccccc2N(CC(O)=O)C1=O)C(O)=O
Target:
Angiotensin-converting Enzyme (ACE)

References

1. Tang JP, Rakhit A, Douglas FL, Melethil S. Effect of chronic hypertension on the blood-brain barrier permeability of libenzapril. Pharm Res. 1992 Feb;9(2):236-43. PubMed PMID: 1553348. 2. Morgan JM, Piraino AJ, Saris SD, Graham CS, Hirschhorn WL, Kochak GM, Choi RL. Inhibition of angiotensin-converting enzyme with libenzapril in normotensive males. J Clin Pharmacol. 1994 Dec;34(12):1177-82. PubMed PMID: 7738213. 3. Kochak GM, Choi RL, deSilva JK, Reydel-Bax P. Pharmacodynamic dependent disposition of the angiotensin converting enzyme inhibitor, libenzapril. J Clin Pharmacol. 1990 Feb;30(2):138-43. PubMed PMID: 2312764. 4. Tang JP, Xu ZQ, Douglas FL, Rakhit A, Melethil S. Increased blood-brain barrier permeability of amino acids in chronic hypertension. Life Sci. 1993;53(25):PL417-20. PubMed PMID: 7902950.